June 29, 2017

FDA: Recall of potassium phosphate and succinylcholine chloride by PharMEDium Services

By: Judy Mathias
Share

Editor's Note

The Food and Drug Administration on June 27 announced the recall by PharMEDium Services of specific lots of potassium phosphate and succinylcholine chloride because of a lack of sterility assurance.

The products being recalled were compounded using certain Hospira products, which were recalled on June 15 because microbial growth was found during a routine simulation of the manufacturing process.

Posted 06/27/2017] AUDIENCE: Pharmacy ISSUE: PharMEDium Services is conducting a limited, voluntary recall due to Hospira Inc.'s ("Hospira") June 15, 2017 recall announcement that microbial growth was detected during a routine simulation of the manufacturing process and therefore there was a lack of sterility assurance.

Read More >>
Live chat by BoldChat